Foam sclerotherapy techniques: Different gases and methods of preparation, catheter versus direct injection

Phlebology

Volumn 24, Issue 6, 2009, Pages 247-251

  Cavezzi, A ^a   Tessari, L ^b  

^a Clinica Stella Maris   (Italy)

^b Fondazione Glauco Bassi   (Italy)

Author keywords

Foam sclerotherapy; Ultrasound guided sclerotherapy

Indexed keywords

CARBON DIOXIDE; POLIDOCANOL; TETRADECYL SULFATE SODIUM; UNCLASSIFIED DRUG; VARISOLVE;

AIR; ARTICLE; CATHETER; DISPOSABLE EQUIPMENT; FOAM; GAS; HUMAN; INJECTION SITE; MICROBUBBLE; NEEDLE; PHLEBECTOMY; PRIORITY JOURNAL; SAPHENOUS VEIN; SCLEROTHERAPY; ULTRASOUND; VARICOSIS;

AIR; CARBON DIOXIDE; CATHETERIZATION, PERIPHERAL; DETERGENTS; DOSAGE FORMS; EQUIPMENT DESIGN; GASES; HUMANS; INJECTIONS, INTRAVENOUS; MICROBUBBLES; NEEDLES; OXYGEN; SAPHENOUS VEIN; SCLEROSING SOLUTIONS; SCLEROTHERAPY; SYRINGES; ULTRASONOGRAPHY, INTERVENTIONAL; VARICOSE VEINS;

EID: 72149132800     PISSN: 02683555     EISSN: 14333031     Source Type: Journal    
DOI: 10.1258/phleb.2009.009061     Document Type: Article

References (41)

1. Tessari L. Nouvelle technique d'obtention de la scleromousse. Phlebologie 2000;53:129-133
2. Wollmann J. The history of sclerosant foams: persons, techniques, patents and medical improvements. In: Bergan J, Van Le Chang, eds. Foam Sclerotherapy: A Textbook. London: Royal Society of Medicine Press, 2008
3. Wollmann J.History and today practice in sclerosant foam preparation. See http://www.cavezzi.it/History-and-today-practice-in-sclerosant-foam- preparation.pdf (last accessed 22 September 2009)
4. Morrison N. Foam sclerotherapy, how to improve results and reduce side effects. Phlébologie 2009;62:23-34
5. Tessari L, Cavezzi A, Rosso M, Cabrera Garrido A. Variables in foam sclerotherapy: literature and experimental data. ANZJ Phleb 2008;11:83-84
6. Hamel-Desnos C, Desnos P, Wollmann JC, Ouvry P, Mako S, Allaert FA. Evaluation of the efficacy of polidocanol in the form of foam compared to liquid form in sclerotherapy of the long saphenous vein. Dermatol Surg 2003;29:1170-1175 (Pubitemid 38009913)
7. Hamel-Desnos C, Allaert FA, Benigni JP, et al. Etude 3/1 mousse de polidocanol 3% versus 1% dans la grande veine saphène: premiers résultats. Phlébologie 2005;2:175-182
8. Shirazi AR, Goldman MP. The use of a 5-microm filter hub increases foam stability when using the double syringe technique. Dermatol Surg 2008;34:91-92
9. Cabrera J, Cabrera J Jr. Nuevo metodo de esclerosis en las varices tronculares. Patologia Vasc 1995;4:55-73
10. Cabrera Garrido AL, Cabrera Nyst B. Endoluminal Therapy with Echo-guided Sclerosant Foam: Current Situation after Thirty Years of Experience. S. Diego 2003 UIP Interim World Congress Abstract Book:A-30
11. Eckmann DM, Kobayashi S, Li M. Microvascular embolization following polidocanol microfoam sclerosant administration. Dermatol Surg 2005;31:636-643 (Pubitemid 43093414)
12. Morrison N, Neuhardt DL, Rogers CR, et al. Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation. J Vasc Surg 2008;47:830-836
13. Calliada F, Campani R, Bottinelli O, Bozzini A, Sommaruga MG. Ultrasound contrast agents: basic principles. Eur J Radiol 1998;27 (suppl. 2):157-160 (Pubitemid 28270589)
14. Wright D, Harman A, Robinson N, et al. Patent application publication. US 2008/0274060 A1, 6 November 2008
15. Durant TM, Stauffer HM, Oppenheimer MJ, Paul RE. Safety of intravascular carbon dioxide and the use for roentgenologic visualization of intracardiac structures. Ann Intern Med 1957;47:191-201
16. Munoz S, Berti C, Pulido C, Blanco P. Two-dimensional contrast echocardiography with carbon dioxide in the detection of congenital cardiac shunts. Am J Cardiol 1984;53:206-210 (Pubitemid 14217536)
17. 2) digital subtraction angiography: 26-year experience at the University of Florida. Eur Radiol 1998;8:391-402
18. Weaver FA, Penecost MJ, Yellin AE. Carbon dioxide digital subtraction arteriography: a pilot study. Ann Vasc Surg 1990;4:437-441
19. 2 as a contrast agent. AJR Am J Roentgenol 2003;181:485-489
20. Tsutsui JM, Xie F, Porter RT. The use of microbubbles to target drug delivery. Cardiovasc Ultrasound 2004;2:23-29
21. Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 2001;27:58-60 (Pubitemid 32107620)
22. Myers KA, Jolley D, Clough A, Kirwan J. Outcome of ultrasound-guided sclerotherapy for varicose veins: medium-term results assessed by ultrasound surveillance. Eur J Vasc Endovasc Surg 2007;33:116-121 (Pubitemid 44872674)
23. Jia X, Mowatt G, Burr JM, Cassar K, Cook J, Fraser C. Systematic review of foam sclerotherapy for varicose veins. Br J Surg 2007;94:925-936 (Pubitemid 47236534)
24. Lai SW, Goldman MP. Does the relative silicone content of different syringes affect the stability of foam in sclerotherapy? J Drugs Dermatol 2008;7:399-400
25. Ferrara E, Bernbach HR. Efficacitè de la sclerotherapie à la mousse en fonction de l'aiguille utiliseè. Phlébologie Ann Vasc 2005;58:229-234
26. Wright D, Gobin JP, Bradbury AW, et al. Varisolve® polidocanol microfoam compared with surgery or sclerotherapy in the management of varicose veins in the presence of trunk vein incompetence: European randomized controlled trial. Phlebology 2006;21:180-190 (Pubitemid 44913249)
27. Rabe E, Otto J, Schliephake D, Pannier F. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial. Eur J Vasc Endovasc Surg 2008;35:238-245 (Pubitemid 351163086)
28. Tessari L. Mousse de sclérosant et utilisation d'uncathéter endoveineux dans le traitement de l'insuffisance veineuse superficielle. Phlébologie Ann Vasc 2002;55:293-297
29. Parsi K. Catheter-directed sclerotherapy. Phlebology 2009;24:98-107
30. Wildenhues B. Endovenöse kathetergestützte Schaumsklerosierung. Phlebologie 2005;34:165-170
31. Brodersen JP, Geismar U. Catheter-assisted vein sclerotherapy: a new approach foam sclerotherapy of the greater saphenous vein with a double-lumen balloon catheter. Dermatol Surg 2007;33:469-475 (Pubitemid 46570122)
32. Kölbel T, Hinchliffe RJ, Lindblad B. Catheter-directed foam sclerotherapy of axial saphenous reflux: early results. Phlebology 2007;22:210-222
33. Hahn M, Schulz T, Jünger M. Outcome four years after transcatheter foam sclerotherapy of the greater saphenous vein. Phlebologie Germany 2008;37:237-240
34. Almeida JI, Raines JK. Catheter-directed sclerotherapy for saphenous vein incompetence. An update on the recent progress and current areas of clinical study and development using this therapeutic option. Endovasc Today 2008;39:32-34
35. Cavezzi A, Carigi V, Buresta P, Di Paolo S, Sigismondi G. Comunicaciòn preliminar: flebectomìa de las varices + espuma sclerosante del del tronco safenico: una propuesta terapèutica innovadora. FlebolLinfol Lect Vasc 2008;3:426-428
36. Thibault P. Internal compression (peri-venous) following ultrasound guided sclerotherapy to the great and small saphenous veins. Aust NZ J Phleb 2005;9:29-32
37. Parsi K, Exner T, Connor DE, Herbert A, Ma DDF, Joseph JE. The lytic effects of detergent sclerosants on erythrocytes, platelets, endothelial cells and microparticles are attenuated by albumin and other plasma components in vitro. Eur J Vasc Endovasc Surg 2008;36:216-223 (Pubitemid 351952328)
38. Milleret R, Garandeau C, Brel D, Allaert FA. Foam sclerotherapy of the great saphenous veins via ultrasound-guided catheter in an empty vein: the alpha-technique. Phlebologie 2004;57:15-18
39. nd European Consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany. Vasa 2008;37:90-95
40. Yamaki T, Nozaki M, Sakurai H, Takeuchi M, Soejima K, Kono T. Multiple small-dose injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins. Eur J Vasc Endovasc Surg 2009;37:343-348
41. Myers KA, Jolley D. Factors affecting the risk of deep venous occlusion after ultrasoundguided sclerotherapy for varicose veins. Eur J Vasc Endovasc Surg 2008;36:602-605